S-ADHF：Sarcopenia in Patients With ADHF
This is a prospective, multi-center, investigator-initiated observational cohort study. Enrollment with a minimum of of 195 cases each for patients with and without sarcopenia. Each patient is followed up for 6 month, 1 year, 2 years or until the occurrence of death.This study will examine the correlation between sarcopenia and prognosis in different subgroups of patients, and explore the additive effect of different comorbidities and sarcopenia on prognosis in patients with acute decompensated heart failure.
- EligibilityCriteria: Inclusion Criteria:  Age ≥18 years At least one symptom of heart failure upon admission:Dyspnea at rest or with exertion, orthopnea, paroxysmal nocturnal dyspnea or exertional fatigue. At least two of the signs of heart failure (HF):  Distended jugular veins, enlarged cardiac silhouette, apex beat displacement, third heart sound, or increased jugular venous pressure/central venous pressure/pulmonary capillary wedge pressure.  Pulmonary edema or pulmonary congestion (rales or chest X-ray/CT evidence of pulmonary congestion).  Peripheral edema. Elevated B-type natriuretic peptide (>100 pg/ml) or elevated N-Terminal Pro-Brain Natriuretic Peptide (>300 pg/ml).  Willingness to provide informed consent and cooperate with the follow-up  Exclusion Criteria:  Unable to understand and comply with protocol or to give informed consent End-stage diseases other than heart failure, life expectancy <1 year, such as malignant tumors Current or planned participation in a clinical trial. - HealthyVolunteers: No - Gender: All - MinimumAge: 18 Years - StdAgeList: Adult, Older Adult - StudyPopulation: Enrollment of up to 500 participants adults aged over 18 years hospitalized for ADHF is planned, with a minmum of of 195 cases each for patients with and without sarcopenia - SamplingMethod: Non-Probability Sample